David Sparkman-Yager
Company: Wayfinder Biosciences
Job title: Chief Technology Officer
Seminars:
Conformation-Driven Biochemical Screening Approach Discovers Functional RNA Binders that Modulate Myc Translation In Cancer 11:45 am
• Discovering selective binders for translational regulatory elements in the Myc mRNA using Wayfinder’s highly quantitative HTS platform • Validating functional activity and drug-like properties while reaching sub-micromolar potency via compound optimization • Elucidating compound targeting profile and tumor-specific mechanism of actionRead more
day: Conference Day Two